ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma
Open Access
- 1 April 2015
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 106 (6) , 687-691
Abstract
Recent studies have indicated that low circulating adiponectin concentrations are associated with a higher risk of several cancers, including renal cell carcinoma. In this case–control study, we examined the frequency of single nucleotide polymorphisms (rs182052G>A, rs266729C>G, and rs3774262G>A) in the adiponectin gene (ADIPOQ) in 1004 patients with clear cell renal cell carcinoma (ccRCC) compared with a group of healthy subjects (n = 1108). Fasting serum adiponectin concentrations were also examined. Logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (95% CI). The association of serum adiponectin concentration with genetic variants was calculated using a multivariate linear regression model. A significantly higher ccRCC risk was associated with the rs182052 variant A allele (adjusted OR, 1.36 and 95% CI, 1.07–1.74 for AA vs GG, P = 0.013; adjusted OR, 1.27 and 95% CI, 1.04–1.56 for AA vs GG+AG, P = 0.019), and this positive association was more evident in overweight subjects. Fasting serum adiponectin was lower in subjects carrying A alleles of rs182052 in both ccRCC patients (β = −0.399, P = 0.018) and healthy controls (β = −0.371, P = 0.024). These results suggest that ADIPOQ rs182052 is significantly associated with ccRCC risk.Keywords
Funding Information
- Medicine and Health Science Technology Development Project of Shandong Province (2011HW028)
- National Natural Science Foundation of China (NSFC 81001131)
This publication has 44 references indexed in Scilit:
- Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian populationTumor Biology, 2011
- Cancer statistics, 2011CA: A Cancer Journal for Clinicians, 2011
- VHL DiseaseBest Practice & Research Clinical Endocrinology & Metabolism, 2010
- Contemporary Epidemiology of Renal Cell CancerThe Cancer Journal, 2008
- Vitamin D Receptor Polymorphisms and Renal Cancer Risk in Central and Eastern EuropeJournal of Toxicology and Environmental Health, Part A, 2008
- Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese populationInternational Journal of Urology, 2007
- The Epidemiology of Renal Cell CarcinomaJournal of Urology, 2006
- Obesity and renal cell cancer – a quantitative reviewBritish Journal of Cancer, 2001
- Obesity, Hypertension, and the Risk of Kidney Cancer in MenNew England Journal of Medicine, 2000
- Loss of Heterozygosity on the Short Arm of Chromosome 3 in Renal CancerOncology, 2000